Back to Journals » International Journal of Nanomedicine » Volume 10 » Issue 1

Inhibited biofilm formation and improved antibacterial activity of a novel nanoemulsion against cariogenic Streptococcus mutans in vitro and in vivo

Authors Li YF, Sun H, Gao R, Liu KY, Zhang HQ, Fu QH, Qing SL, Guo G, Zou Q

Received 19 August 2014

Accepted for publication 16 October 2014

Published 9 January 2015 Volume 2015:10(1) Pages 447—462


Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 6

Editor who approved publication: Prof. Dr. Thomas J. Webster

Video abstract presented by Hong Wu Sun

Views: 483

Yun Fei Li,1,2,* Hong Wu Sun,1,2,* Rong Gao,1–3,* Kai Yun Liu,1,2 Hua Qi Zhang,4 Qi Huan Fu,1,2 Sheng Li Qing,1,2 Gang Guo,1,2 Quan Ming Zou1,2,*

1National Engineering Research Center of Immunological Products, 2Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, 3Department of Biomedical Engineering, Third Military Medical University of Chinese PLA, Chongqing, People’s Republic of China; 4Wanzhou Institute for Food and Drug Control of Chongqing, Wanzhou, Chongqing, People’s Republic of China

*These authors contributed equally to this work

Abstract: The aim of this study was to prepare a novel nanoemulsion loaded with poorly water-soluble chlorhexidine acetate (CNE) to improve its solubility, and specifically enhance the antimicrobial activity against Streptococcus mutans in vitro and in vivo. In this study, a novel CNE nanoemulsion with an average size of 63.13 nm and zeta potential of −67.13 mV comprising 0.5% CNE, 19.2% Tween 80, 4.8% propylene glycol, and 6% isopropyl myristate was prepared by the phase inversion method. Important characteristics such as the content, size, zeta potential, and pH value of CNE did not change markedly, stored at room temperature for 1 year. Also, compared with chlorhexidine acetate water solution (CHX), the release profile results show that the CNE has visibly delayed releasing effect in both phosphate-buffered saline and artificial saliva solutions (P<0.005). The minimum inhibitory concentration and minimum bactericidal concentration of CHX for S. mutans (both 0.8 µg/mL) are both two times those of CNE (0.4 µg/mL). Besides, CNE of 0.8 µg/mL exhibited fast-acting bactericidal efficacy against S. mutans, causing 95.07% death within 5 minutes, compared to CHX (73.33%) (P<0.01). We observed that 5 mg/mL and 2 mg/mL CNE were both superior to CHX, significantly reducing oral S. mutans numbers and reducing the severity of carious lesions in Sprague Dawley rats (P<0.05), in an in vivo test. CNE treatment at a concentration of 0.2 µg/mL inhibited biofilm formation more effectively than CHX, as indicated by the crystal violet staining method, scanning electron microscopy, and atomic force microscopy. The cell membrane of S. mutans was also severely disrupted by 0.2 µg/mL CNE, as indicated by transmission electron microscopy. These results demonstrated that CNE greatly improved the solubility and antimicrobial activity of this agent against S. mutans both in vitro and in vivo. This novel nanoemulsion is a promising medicine for preventing and curing dental caries.

Keywords: nanoemulsion, chlorhexidine acetate, Streptococcus mutans, antibacterial

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]